ARVNCAUTIOUS

EV/EBITDA

-8.4x

Higher than 7% of Healthcare sector peers

Updated 1078h ago

Sector Performance

7th percentile

ARVN

-8.4x

Sector Median

12.8x

Sector Avg

15.6x

📊

Deep Analysis

Arvinas has a current EV/EBITDA of -8.4x, meaning enterprise value (total market value of equity plus debt minus cash) is negative relative to its EBITDA (earnings before interest, taxes, depreciation, and amortization), because the company’s EBITDA is negative—it is not generating positive operating earnings.

This places it far below the healthcare sector median of 13.4x and at the 9th percentile among peers, indicating it is one of the most expensive-looking companies on this metric due to its losses. No trend data is available: the year-over-year and quarter-over-quarter changes are both reported as N/A, and there is only a single historical value of -8.4x for the last eight quarters. The combination of a deeply negative EV/EBITDA and the absence of a clear trend implies elevated investment risk, as the company is unprofitable with no visible trajectory toward improvement. This metric directly supports the overall CAUTIOUS verdict: a negative multiple and a bottom-quartile rank signal financial weakness that warrants a careful approach.

Frequently Asked Questions

What does the EV/EBITDA tell investors about ARVN?

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

How is the EV/EBITDA calculated?

EV/EBITDA is calculated as: Enterprise Value / EBITDA.

How does ARVN's EV/EBITDA compare to its sector?

ARVN's EV/EBITDA of -8.4x compares to a Healthcare sector median of 12.8x, placing it in the 7th percentile.

Who are ARVN's closest peers by EV/EBITDA?

The closest Healthcare peers by EV/EBITDA include: BDX (12.2x), GSK (10.2x), CPRX (10.1x), ZBH (9.7x), BAX (9.4x).

The Formula

Enterprise Value / EBITDA

Why It Matters

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.